Author: Mariah Taylor

Minnesota has the lowest breast cancer screening recall rate, while New York's rate is about six times higher, according to CMS data.

Four years ago, a study found that cancer has unique microbial signatures that would allow a blood test to diagnose cancer. But in recent months, the study has faced scrutiny for inaccurate data, The Wall Street Journal reported Aug. 30.

Asian American and Pacific Islander women once had relatively low rates of breast cancer, but the demographic is now seeing faster-rising rates of cancer compared to other races — and experts are not sure why, CBS News reported Sep. 3.

Houston-based Memorial Hermann Health System is expanding its partnership with on-demand cancer care company Reimagine Care.

The FDA approved afamitresgene autoleucel, or afami-cel (Tecelra), as the first T-cell receptor therapy for cancer.

Jeffrey Weber, MD, PhD, a pioneer in cancer immunotherapy and melanoma research, recently died of cancer.

Sacramento, Calif.-based UC Davis Health expanded its same-day, in-home urgent care program to patients of UC Davis Comprehensive Cancer Center.

Penn Medicine's Abramson Cancer Center and the Parker Institute for Cancer Immunotherapy have renewed their partnership to advance cancer immunotherapy research.

Irvine, Calif.-based City of Hope Orange County named colorectal surgeon Alessio Pigazzi, MD, PhD, executive medical director of colorectal surgery and vice chair of clinical network affairs for the department of surgery.

Seven health organizations are using Cancer Moonshot funds to reimagine and advance cancer surgery, Politico reported Aug. 14.